ID: MRFR/LS/0283-CR | July 2020 | Region: Global | 148 pages
Global Automated Cell Culture Market was valued at USD 8,579.8 Million in 2019 and is expected to register a CAGR of 8.18% during the forecast period of 2020 to 2027.
Automated cell culture systems are also useful in laboratories that work with multiple functions, such as cell biology, cell signaling, drug discovery, and protein expression. These systems save labor time and reduce technical errors and thus, offer an important and powerful tool in modeling human diseases. Automated cell culture systems have the ability to dilute samples, planting cultures, or placing cultures in wells. However, the lack of awareness regarding advanced techniques and lack of skilled workforce may also pose a challenge for the automated cell culture market growth during the assessment period.
Factors such as growing application for drug discovery & development and stem cell research are anticipated to increase the lucrativeness of investing in the development of novel products. Other applications such as the production of vaccines and gene therapy are expected to surge the size of the automated cell culture market. Moreover, advancement in the development of spheroid and complex bioreactors, and with the introduction of 3D cell culture, the market is anticipated to surge.
Automated cell culture systems are used to offer improved productivity and quality of cell lines without process change. Key players operating in the automated cell culture market are engaged in the approval of products to decrease the available need gap created by demand from customers. For instance, in May 2019, Sartorius AG (Germany) launched Ambr 15 Cell Culture, an automated microbioreactor system. Similarly, in January 2018, Tecan Trading Group AG (Switzerland) launched the Fluent Gx Automation Workstation to be used in regulated laboratories. This product offers the flexibility to meet a host of laboratory needs such as clinical diagnostics, next-generation sequencing, and nucleic acid purification. This system is flexible and has expanding capability for cloning selection, which will enhance researchers’ workflow. In July 2017, Becton, Dickinson, and Company launched new technology (BD Kiestra urine culture app) to automatically report and release negative urine cultures. An increase in product approvals is helping the growth in the automated cell culture market size.
The utility of automated cell culture in various applications such as biopharmaceutical production, diagnostics, gene therapy, drug screening & development, toxicity testing, stem cell research, and tissue engineering & regenerative medicine is anticipated to increase the market growth. Apart from its utility in various applications, the rising number of mergers and acquisitions is anticipated to grow the market size. For example, Thermo Fisher Scientific Inc., completed the acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, in May 2019. In December 2019. F. Hoffmann-La Roche Ltd acquired Spark Therapeutics, Inc., based in Philadelphia, Pennsylvania, a fully integrated, commercial company committed to discovering, developing, and delivering gene therapies for genetic diseases. The acquisition of companies to broaden manufacturing capacity and expansion of geographical reach is one of the strategic decisions taken by key players that are driving the market growth. However, the availability of a skilled workforce and fluctuating prices of consumables during the pandemic is expected to hamper the market growth.
Global Automated cell culture Market Share, by Type, 2019 (%)
Source: MRFR Analysis
Global Automated Cell Culture Market has been divided based on Type, Product, Application and End User.
The market, based on type, has been bifurcated into modular automation and whole lab automation. The modular automation segment accounted for the largest market share of 67.1% in 2019. This largest share can be attributed to its preference over whole lab automation.
The market, based on the product, has been bifurcated into consumables and vessels. Consumables segment dominated the global automated cell culture market with a share of 67.1% in 2019. Consumables used in automated cell culture are segmented into media, sera, reagents, and others. The wide application of consumables is expected to surge the market size of the segment. The vessel segment includes roller/roux bottles, multiwell plates, flasks, and Petri dishes.
On the basis of application, the global automated cell culture market has been classified as biopharmaceutical production, diagnostics, gene therapy, drug screening and development, toxicity testing, stem cell research, tissue engineering & regenerative medicine and others. The biopharmaceutical production segment dominated the global automated cell culture market with a share of 22.1% in 2019. According to LePro PharmaCompass, six of the top 10 drugs with sales of USD 59 billion were recombinant protein biopharmaceuticals manufactured in animal cells in 2015.
The market, based on end-user, has been segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research institutes, and cell banks. Pharmaceutical & Biotechnology Companies segment dominated the global automated cell culture market with a share of 37.8%in 2019.
Global Automated cell culture Market Share, by Region, 2019 (%)
Source: MRFR Analysis
Global Automated Cell Culture Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to dominate the global automated cell culture market owing to the presence of major manufacturers, rising investment for manufacturers, and rising product launches by major players in the region. In 2019, the Americas accounted for the largest market share of 42.8% in the global automated cell culture market. This large share is majorly attributed to the presence of major automated cell culture players, and a large number of diagnostic tests for various applications. According to the most recent data from The Alliance for Regenerative Medicine, companies active in gene and cell therapies and other regenerative medicines globally raised nearly USD 2.6 billion in the third quarter of 2019.
The automated cell culture market in Europe is expected to propel during the forecast period, owing to factors such as the increasing presence of major manufacturers, rising prevalence of chronic diseases, an increase in the geriatric population, and well-developed healthcare infrastructure. For instance, The “Health at a Glance: Europe 2016” report by the European Commission and the Organization for Economic Co-operation and Development (OECD) shows that the employment rate of people who have one or more chronic condition, and particularly people aged 50-59, is much lower than for those who do not suffer from any disease.
The fast growth of the Asia-Pacific region is due to the rising geriatric population, increasing number of patients suffering from oncological problems, and the increasing per capita income along with government initiatives to enhance the quality of healthcare.
The market growth in the Middle East & Africa can be attributed to the novel public-private partnerships (PPP) business model, developing healthcare infrastructure, and government support. The presence of cell banks and medical tourism in the region is expected to generate demand for automated cell culture. The notable cell banking service providers in the region include Cryo-Save, Discovery Limited, Netcells Kenya Future Health Biobank, among others.
The Prominent Players in the Global Automated Cell Culture Market are Tecan Trading AG (Switzerland), Siemens Healthcare GmbH (Germany), Hitachi, Ltd (Japan), Thermo Fisher Scientific (US), Sartorius Stedim Biotech Group (Germany), Hamilton Company (US), Beckman Coulter, Inc. (US), F. Hoffmann-La Roche (Switzerland), Becton, Dickinson, and Company (US) among others.
Global Automated cell culture Market, by Type
Global Automated cell culture Market, by Product
Global Automated cell culture Market, by Application
Global Automated cell culture Market, by End-user
Global Automated cell culture Market, by Region
Available Additional Customizations
Frequently Asked Questions (FAQ) :
The CAGR would be 8.5% during the forecast period of 2020-2027.
Lack of technical knowledge and expertise and high value of the machines could prevent the market from growing with the expected growth rate.
The end user is academic institutes, research organizations, biotech companies, and others.
The major consumables discussed are media, sera, and reagents.
The types included are finite cell line cultures and infinite cell line cultures.